Different effects of L-type and L+N-type calcium channel blockers on hamster cheek pouch venules

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 6, 2004, Pages 672-675

  Kushiro, Toshio ^a   Watanabe, Nagaoki ^a   Takahashi, Atsuhiko ^a   Koike, Miyuki ^a   Saito, Fumio ^a   Otsuka, Yuji ^a   Kanmatsuse, Katsuo ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Calcium channel blocker; L type calcium channel; N type calcium channel

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CILNIDIPINE; DIHYDROPYRIDINE DERIVATIVE; NIFEDIPINE; OMEGA CONOTOXIN;

ANIMAL MODEL; ARTERIOLE; ARTERY DILATATION; ARTERY RESISTANCE; ARTICLE; CHEEK POUCH; HAMSTER; MALE; NONHUMAN; PRIORITY JOURNAL; VEIN DIAMETER; VEIN DILATATION; VENULE;

ANIMALS; ARTERIOLES; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, N-TYPE; CRICETINAE; DIHYDROPYRIDINES; MALE; MESOCRICETUS; MOUTH MUCOSA; NIFEDIPINE; OMEGA-CONOTOXINS; REGIONAL BLOOD FLOW; VENULES;

EID: 9744273099     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200412000-00008     Document Type: Article

References (27)

1. Godfraind T. Calcium antagonists and vasodilatation. Pharmacol Ther. 1994;64:37-75.
2. Morel N, Buryi V, Feron O, et al. The action of calcium channel blockers on recombinant L-type calcium channel alpha1-subunits. Br J Pharmacol. 1998;125:1005-1012.
3. Uneyama H, Takahara A, Wakamori M, et al. Pharmacology of N-type Ca2+ channels distributed in cardiovascular system. Int J Mol Med. 1999;3:455-466.
4. Smyth L, Bobalova J, Ward SM, et al. Cotransmission from sympathetic vasoconstrictor neurons: differences in guinea-pig mesenteric artery and vein. Auton Neurosci. 2000;86:18-29.
5. Duling BR. The preparation and use of the hamster cheek pouch for studies of the microcirculation. Microvasc Res. 1973;5:423-429.
6. Messing M, Van Essen H, Smith TL, et al. Microvascular actions of calcium channel antagonists. Eur J Pharmacol. 1991;198:189-195.
7. Malvin GM, Walker BR. Sites and ionic mechanisms of hypoxic vasoconstriction in frog skin. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1308-R1314.
8. Weir MR. Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance. J Clin Hypertens (Greenwich). 2003;5:330-335.
9. Zanchetti A, Omboni S, La Commare P, et al. Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension. J Cardiovasc Pharmacol. 2001;38:642-650.
10. Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet. 2000;356:366-372.
11. Julius S, Kjeldsen SE, Weber M, et al. The VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022-2031.
12. Pedrinelli R, Dell'Omo G, Nuti M, et al. Heterogeneous effect of calcium antagonists on leg oedema: a comparison of amlodipine versus lercanidipine in hypertensive patients. J Hypertens. 2003;21:1969-1973.
13. Pedrinelli R, Dell'Omo G, Melillo E, et al. Amlodipine, enalapril, and dependent leg edema in essential hypertension. Hypertension. 2000;35:621-625.
14. Mori Y, Nishida M, Shimizu S, et al. Ca(2+) channel alpha(1B) subunit (Ca(V) 2.2) knockout mouse reveals a predominant role of N-type channels in the sympathetic regulation of the circulatory system. Trends Cardiovasc Med. 2002;12:270-275.
15. Uneyama H, Uchida H, Konda T, et al. Cilnidipine: Preclinical profile and clinical evaluation. Cadiovasc Drug Rev. 1999;17:341-357.
16. Uchida R, Yamazaki J, Kitamura K. Characterization of Ca2+ current inhibition by cilnidipine using a beta-subunit antisense oligonucleotide. Eur J Pharmacol. 2003;466:53-62.
17. Takahara A, Fujita S, Moki K, et al. Neuronal Ca2+ channel blocking action of an antihypertensive drug, cilnidipine, in IMR-32 human neuroblastoma cells. Hypertens Res. 2003;26:743-747.
18. Minami J, Kawano Y, Makino Y, et al. Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension. Br J Clin Pharmacol. 2000;50:615-620.
19. Hosono M, Fujii S, Hiruma T, et al. Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats. Jpn J Pharmacol. 1995;69:127-134.
20. Sakaki T, Naruse H, Masai M, et al. Cilnidipine as an agent to lower blood pressure without sympathetic nervous activation as demonstrated by iodine-123 metaiodobenzylguanidine imaging in rat hearts. Ann Nucl Med. 2003;17:321-326.
21. Sakata K, Shirotani M, Yoshida H, et al. Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension. Hypertension. 1999;33:1447-1452.
22. Minami J, Ishimitsu T, Higashi T, et al. Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertensive patients. Hypertens Res. 1998;21:215-219.
23. Kitahara Y, Saito F, Akao M, et al. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients. J Cardiovasc Pharmacol. 2004;43:68-73.
24. Taherzadeh M, Das AK, Warren JB. Nifedipine increases microvascular permeability via a direct local effect on postcapillary venules. Am J Physiol. 1998;275:H1388-H1394.
25. Bouskela E, Cyrino FZ, Marcelon G. Effects of Ruscus extract on the internal diameter of arterioles and venules of the hamster cheek pouch microcirculation. J Cardiovasc Pharmacol. 1993;22:221-224.
26. Nielsen KJ, Schroeder T, Lewis R. Structure-activity relationships of omega-conotoxins at N-type voltage-sensitive calcium channels. J Mol Recognit. 2000;13:55-70.
27. Fabi F, Chiavarelli M, Argiolas L, et al. Evidence for sympathetic neurotransmission through presynaptic N-type calcium channels in human saphenous vein. Br J Pharmacol. 1993;110:338-342.